495 related articles for article (PubMed ID: 25010142)
1. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients.
Kistowska M; Meier B; Proust T; Feldmeyer L; Cozzio A; Kuendig T; Contassot E; French LE
J Invest Dermatol; 2015 Jan; 135(1):110-118. PubMed ID: 25010142
[TBL] [Abstract][Full Text] [Related]
2. Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D.
Agak GW; Qin M; Nobe J; Kim MH; Krutzik SR; Tristan GR; Elashoff D; Garbán HJ; Kim J
J Invest Dermatol; 2014 Feb; 134(2):366-373. PubMed ID: 23924903
[TBL] [Abstract][Full Text] [Related]
3. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
4. Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin.
Agak GW; Kao S; Ouyang K; Qin M; Moon D; Butt A; Kim J
J Invest Dermatol; 2018 Feb; 138(2):316-324. PubMed ID: 28864077
[TBL] [Abstract][Full Text] [Related]
5. IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo.
Kistowska M; Gehrke S; Jankovic D; Kerl K; Fettelschoss A; Feldmeyer L; Fenini G; Kolios A; Navarini A; Ganceviciene R; Schauber J; Contassot E; French LE
J Invest Dermatol; 2014 Mar; 134(3):677-685. PubMed ID: 24157462
[TBL] [Abstract][Full Text] [Related]
6. Inflammasome activation by Propionibacterium acnes: the story of IL-1 in acne continues to unfold.
Thiboutot DM
J Invest Dermatol; 2014 Mar; 134(3):595-597. PubMed ID: 24518111
[TBL] [Abstract][Full Text] [Related]
7. Propionibacterium acnes Strains Differentially Regulate the Fate of Th17 Responses in the Skin.
Contassot E; French LE
J Invest Dermatol; 2018 Feb; 138(2):251-253. PubMed ID: 29389326
[TBL] [Abstract][Full Text] [Related]
8. New insights into acne pathogenesis: propionibacterium acnes activates the inflammasome.
Contassot E; French LE
J Invest Dermatol; 2014 Feb; 134(2):310-313. PubMed ID: 24424454
[TBL] [Abstract][Full Text] [Related]
9. Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes.
Yu Y; Champer J; Agak GW; Kao S; Modlin RL; Kim J
J Invest Dermatol; 2016 Nov; 136(11):2221-2228. PubMed ID: 27377696
[TBL] [Abstract][Full Text] [Related]
10. Propionibacterium acnes-Derived Extracellular Vesicles Promote Acne-Like Phenotypes in Human Epidermis.
Choi EJ; Lee HG; Bae IH; Kim W; Park J; Lee TR; Cho EG
J Invest Dermatol; 2018 Jun; 138(6):1371-1379. PubMed ID: 29409885
[TBL] [Abstract][Full Text] [Related]
11. Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes.
Qin M; Pirouz A; Kim MH; Krutzik SR; Garbán HJ; Kim J
J Invest Dermatol; 2014 Feb; 134(2):381-388. PubMed ID: 23884315
[TBL] [Abstract][Full Text] [Related]
12. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
13. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris.
Mouser PE; Baker BS; Seaton ED; Chu AC
J Invest Dermatol; 2003 Nov; 121(5):1226-8. PubMed ID: 14708633
[No Abstract] [Full Text] [Related]
14. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes.
Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E
Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234
[TBL] [Abstract][Full Text] [Related]
15. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
Wang Y; Hata TR; Tong YL; Kao MS; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2018 Nov; 138(11):2355-2364. PubMed ID: 29964032
[TBL] [Abstract][Full Text] [Related]
16. Induction of toll-like receptors by Propionibacterium acnes.
Jugeau S; Tenaud I; Knol AC; Jarrousse V; Quereux G; Khammari A; Dreno B
Br J Dermatol; 2005 Dec; 153(6):1105-13. PubMed ID: 16307644
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris.
Caillon F; O'Connell M; Eady EA; Jenkins GR; Cove JH; Layton AM; Mountford AP
Br J Dermatol; 2010 Feb; 162(2):296-303. PubMed ID: 19796181
[TBL] [Abstract][Full Text] [Related]
18. IL-17: a key player in the P. acnes inflammatory cascade?
Thiboutot DM; Layton AM; Anne Eady E
J Invest Dermatol; 2014 Feb; 134(2):307-310. PubMed ID: 24424453
[TBL] [Abstract][Full Text] [Related]
19. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
